Literature DB >> 26961858

Viability and Functionality of Cryopreserved Peripheral Blood Mononuclear Cells in Pediatric Dengue.

Federico Perdomo-Celis1, Doris M Salgado1,2, Diana M Castañeda1, Carlos F Narváez3.   

Abstract

Cryopreserved peripheral blood mononuclear cells (PBMCs) are widely used in studies of dengue. In this disease, elevated frequency of apoptotic PBMCs has been described, and molecules such as soluble tumor necrosis factor (TNF)-related apoptosis-inducing ligands (sTRAIL) are involved. This effect of dengue may affect the efficiency of PBMC cryopreservation. Here, we evaluate the viability (trypan blue dye exclusion and amine-reactive dye staining) and functionality (frequency of gamma interferon [IFN-γ]-producing T cells after polyclonal stimulation) of fresh and cryopreserved PBMCs from children with dengue (in acute and convalescence phases), children with other febrile illnesses, and healthy children as controls. Plasma sTRAIL levels were also evaluated. The frequencies of nonviable PBMCs detected by the two viability assays were positively correlated (r = 0.74; P < 0.0001). Cryopreservation particularly affected the PBMCs of children with dengue, who had a higher frequency of nonviable cells than healthy children and children with other febrile illnesses (P ≤ 0.02), and PBMC viability levels were restored in the convalescent phase. In the acute phase, an increased frequency of CD3+ CD8+ amine-positive cells was found before cryopreservation (P = 0.01). Except for B cells in the acute phase, cryopreservation usually did not affect the relative frequencies of viable PBMC subpopulations. Dengue infection reduced the frequency of IFN-γ-producing CD3+ cells after stimulation compared with healthy controls and convalescent-phase patients (P ≤ 0.003), and plasma sTRAIL correlated with this decreased frequency in dengue (rho = -0.56; P = 0.01). Natural dengue infection in children can affect the viability and functionality of cryopreserved PBMCs.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26961858      PMCID: PMC4860468          DOI: 10.1128/CVI.00038-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  48 in total

1.  CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays.

Authors:  Christian R Kreher; Markus T Dittrich; Robert Guerkov; Bernhard O Boehm; Magdalena Tary-Lehmann
Journal:  J Immunol Methods       Date:  2003-07       Impact factor: 2.303

2.  Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot.

Authors:  Johannes Trück; Ruth Mitchell; Amber J Thompson; Begonia Morales-Aza; Elizabeth A Clutterbuck; Dominic F Kelly; Adam Finn; Andrew J Pollard
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis.

Authors:  Khin S Myint; Timothy P Endy; Duangrat Mongkolsirichaikul; Choompun Manomuth; Siripen Kalayanarooj; David W Vaughn; Ananda Nisalak; Sharone Green; Alan L Rothman; Francis A Ennis; Daniel H Libraty
Journal:  J Infect Dis       Date:  2006-07-31       Impact factor: 5.226

4.  Enzyme-linked immunospot assay for detection of human respiratory syncytial virus f protein-specific gamma interferon-producing T cells.

Authors:  Kathryn Patton; Shahin Aslam; Jim Lin; Li Yu; Stacie Lambert; Glenn Dawes; Mark T Esser; Jennifer Woo; Sylvia Janetzki; Anu Cherukuri
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

5.  TRAIL is a novel antiviral protein against dengue virus.

Authors:  Rajas V Warke; Katherine J Martin; Kris Giaya; Sunil K Shaw; Alan L Rothman; Irene Bosch
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 6.  Development of immunity in early life.

Authors:  Anu Goenka; Tobias R Kollmann
Journal:  J Infect       Date:  2015-04-28       Impact factor: 6.072

7.  Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay.

Authors:  Marie Wunsch; Richard Caspell; Stefanie Kuerten; Paul V Lehmann; Srividya Sundararaman
Journal:  Cells       Date:  2015-01-09       Impact factor: 6.600

8.  Vascular leakage in dengue hemorrhagic Fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production.

Authors:  Sirichan Chunhakan; Punnee Butthep; Sutee Yoksan; Kanchana Tangnararatchakit; Ampaiwan Chuansumrit
Journal:  Int J Vasc Med       Date:  2015-02-05

9.  Dengue virus activates membrane TRAIL relocalization and IFN-α production by human plasmacytoid dendritic cells in vitro and in vivo.

Authors:  Mariana Gandini; Christophe Gras; Elzinandes Leal Azeredo; Luzia Maria de Oliveira Pinto; Nikaïa Smith; Philippe Despres; Rivaldo Venâncio da Cunha; Luiz José de Souza; Claire Fernandes Kubelka; Jean-Philippe Herbeuval
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06

10.  Optimization of Human Peripheral Blood Mononuclear Cells (PBMCs) Cryopreservation.

Authors:  Robab Nazarpour; Ebrahim Zabihi; Ebrahim Alijanpour; Zeinab Abedian; Hamid Mehdizadeh; Fatemeh Rahimi
Journal:  Int J Mol Cell Med       Date:  2012
View more
  3 in total

1.  Delphinidin diminishes in vitro interferon-γ and interleukin-17 producing cells in patients with psoriatic disease.

Authors:  Sotirios G Tsiogkas; Αthanasios Mavropoulos; Dimitrios N Skyvalidas; Eleni Patrikiou; Niki Ntavari; Athina Ioanna Daponte; Maria G Grammatikopoulou; Efthimios Dardiotis; Aggeliki-Victoria Roussaki-Schulze; Lazaros I Sakkas; Efterpi Zafiriou; Dimitrios P Bogdanos
Journal:  Immunol Res       Date:  2021-11-25       Impact factor: 2.829

2.  Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection.

Authors:  Dulharie T Wijeratne; Samitha Fernando; Laksiri Gomes; Chandima Jeewandara; Anushka Ginneliya; Supun Samarasekara; Ananda Wijewickrama; Clare S Hardman; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  PLoS Negl Trop Dis       Date:  2018-10-01

3.  Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Daniel Missailidis; Oana Sanislav; Claire Y Allan; Sarah J Annesley; Paul R Fisher
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.